474 related articles for article (PubMed ID: 29432300)
1. Dopamine modulates striatal response to reward and punishment in patients with Parkinson's disease: a pharmacological challenge fMRI study.
Argyelan M; Herzallah M; Sako W; DeLucia I; Sarpal D; Vo A; Fitzpatrick T; Moustafa AA; Eidelberg D; Gluck M
Neuroreport; 2018 May; 29(7):532-540. PubMed ID: 29432300
[TBL] [Abstract][Full Text] [Related]
2. Ventral striatal network connectivity reflects reward learning and behavior in patients with Parkinson's disease.
Petersen K; Van Wouwe N; Stark A; Lin YC; Kang H; Trujillo-Diaz P; Kessler R; Zald D; Donahue MJ; Claassen DO
Hum Brain Mapp; 2018 Jan; 39(1):509-521. PubMed ID: 29086460
[TBL] [Abstract][Full Text] [Related]
3. Effects of dopamine on reinforcement learning in Parkinson's disease depend on motor phenotype.
van Nuland AJ; Helmich RC; Dirkx MF; Zach H; Toni I; Cools R; den Ouden HEM
Brain; 2020 Dec; 143(11):3422-3434. PubMed ID: 33147621
[TBL] [Abstract][Full Text] [Related]
4. Dorsal striatum does not mediate feedback-based, stimulus-response learning: An event-related fMRI study in patients with Parkinson's disease tested on and off dopaminergic therapy.
Hiebert NM; Owen AM; Ganjavi H; Mendonça D; Jenkins ME; Seergobin KN; MacDonald PA
Neuroimage; 2019 Jan; 185():455-470. PubMed ID: 30394326
[TBL] [Abstract][Full Text] [Related]
5. Reward-learning and the novelty-seeking personality: a between- and within-subjects study of the effects of dopamine agonists on young Parkinson's patients.
Bódi N; Kéri S; Nagy H; Moustafa A; Myers CE; Daw N; Dibó G; Takáts A; Bereczki D; Gluck MA
Brain; 2009 Sep; 132(Pt 9):2385-95. PubMed ID: 19416950
[TBL] [Abstract][Full Text] [Related]
6. Dopaminergic basis for impairments in functional connectivity across subdivisions of the striatum in Parkinson's disease.
Bell PT; Gilat M; O'Callaghan C; Copland DA; Frank MJ; Lewis SJ; Shine JM
Hum Brain Mapp; 2015 Apr; 36(4):1278-91. PubMed ID: 25425542
[TBL] [Abstract][Full Text] [Related]
7. Dopamine depletion impairs gait automaticity by altering cortico-striatal and cerebellar processing in Parkinson's disease.
Gilat M; Bell PT; Ehgoetz Martens KA; Georgiades MJ; Hall JM; Walton CC; Lewis SJG; Shine JM
Neuroimage; 2017 May; 152():207-220. PubMed ID: 28263926
[TBL] [Abstract][Full Text] [Related]
8. Dopaminergic modulation of striato-frontal connectivity during motor timing in Parkinson's disease.
Jahanshahi M; Jones CR; Zijlmans J; Katzenschlager R; Lee L; Quinn N; Frith CD; Lees AJ
Brain; 2010 Mar; 133(Pt 3):727-45. PubMed ID: 20305278
[TBL] [Abstract][Full Text] [Related]
9. Greater striatal responses to medication in Parkinson׳s disease are associated with better task-switching but worse reward performance.
Aarts E; Nusselein AA; Smittenaar P; Helmich RC; Bloem BR; Cools R
Neuropsychologia; 2014 Sep; 62():390-7. PubMed ID: 24912070
[TBL] [Abstract][Full Text] [Related]
10. Effects of levodopa on corticostriatal circuits supporting working memory in Parkinson's disease.
Simioni AC; Dagher A; Fellows LK
Cortex; 2017 Aug; 93():193-205. PubMed ID: 28675834
[TBL] [Abstract][Full Text] [Related]
11. Functional specialization within the striatum along both the dorsal/ventral and anterior/posterior axes during associative learning via reward and punishment.
Mattfeld AT; Gluck MA; Stark CE
Learn Mem; 2011; 18(11):703-11. PubMed ID: 22021252
[TBL] [Abstract][Full Text] [Related]
12. Dopamine is associated with prioritization of reward-associated memories in Parkinson's disease.
Sharp ME; Duncan K; Foerde K; Shohamy D
Brain; 2020 Aug; 143(8):2519-2531. PubMed ID: 32844197
[TBL] [Abstract][Full Text] [Related]
13. Reward learning deficits in Parkinson's disease depend on depression.
Timmer MHM; Sescousse G; van der Schaaf ME; Esselink RAJ; Cools R
Psychol Med; 2017 Oct; 47(13):2302-2311. PubMed ID: 28374660
[TBL] [Abstract][Full Text] [Related]
14. Dopamine agonists diminish value sensitivity of the orbitofrontal cortex: a trigger for pathological gambling in Parkinson's disease?
van Eimeren T; Ballanger B; Pellecchia G; Miyasaki JM; Lang AE; Strafella AP
Neuropsychopharmacology; 2009 Dec; 34(13):2758-66. PubMed ID: 19741594
[TBL] [Abstract][Full Text] [Related]
15. Parkinson's disease duration determines effect of dopaminergic therapy on ventral striatum function.
MacDonald AA; Monchi O; Seergobin KN; Ganjavi H; Tamjeedi R; MacDonald PA
Mov Disord; 2013 Feb; 28(2):153-60. PubMed ID: 23165957
[TBL] [Abstract][Full Text] [Related]
16. Distinct alterations in Parkinson's medication-state and disease-state connectivity.
Ng B; Varoquaux G; Poline JB; Thirion B; Greicius MD; Poston KL
Neuroimage Clin; 2017; 16():575-585. PubMed ID: 28971008
[TBL] [Abstract][Full Text] [Related]
17. Dissociating the cognitive effects of levodopa versus dopamine agonists in a neurocomputational model of learning in Parkinson's disease.
Moustafa AA; Herzallah MM; Gluck MA
Neurodegener Dis; 2013; 11(2):102-11. PubMed ID: 23128796
[TBL] [Abstract][Full Text] [Related]
18. Dopaminergic modulation of cognitive interference after pharmacological washout in Parkinson's disease.
Fera F; Nicoletti G; Cerasa A; Romeo N; Gallo O; Gioia MC; Arabia G; Pugliese P; Zappia M; Quattrone A
Brain Res Bull; 2007 Sep; 74(1-3):75-83. PubMed ID: 17683792
[TBL] [Abstract][Full Text] [Related]
19. Combined insular and striatal dopamine dysfunction are associated with executive deficits in Parkinson's disease with mild cognitive impairment.
Christopher L; Marras C; Duff-Canning S; Koshimori Y; Chen R; Boileau I; Segura B; Monchi O; Lang AE; Rusjan P; Houle S; Strafella AP
Brain; 2014 Feb; 137(Pt 2):565-75. PubMed ID: 24334314
[TBL] [Abstract][Full Text] [Related]
20. Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: a study with positron emission tomography and [11C]raclopride.
Antonini A; Schwarz J; Oertel WH; Pogarell O; Leenders KL
Mov Disord; 1997 Jan; 12(1):33-8. PubMed ID: 8990051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
